[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 1,983
Sort by:
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 113 pages
Erectile Dysfunction - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 150 pages
Male Hypogonadism - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 107 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 176 pages
Amyloidosis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 226 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 83 pages
Rheumatoid Arthritis - Pipeline Review, H1 2020 US$ 2,500.00

... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 1156 pages
Smallpox - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 81 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 129 pages
Cholera - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 63 pages
Typhoid Fever - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 52 pages
Diabetic Macular Edema - Pipeline Review, H1 2020 US$ 2,000.00

... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 298 pages
Sarcopenia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 91 pages
Anthrax - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 110 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 199 pages
Hypoglycemia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 88 pages
Mumps - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 31 pages
Warts - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 111 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020 US$ 2,000.00

... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 99 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 146 pages
Insulin Resistance - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 51 pages
Bacterial Vaginosis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 72 pages
Degenerative Disc Disease - Pipeline Review, H1 2020 US$ 2,000.00

... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 68 pages
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2020 US$ 2,000.00

... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 86 pages
Plague - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 70 pages
Botulism - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 36 pages
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Opioid-Induced Constipation (OIC) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Opioid-Induced Constipation (OIC) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 53 pages
Lyme Disease - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 59 pages
Streptococcus pyogenes Infections - Pipeline Review, H1 2020 US$ 2,000.00

... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 35 pages
Community Acquired Pneumonia - Pipeline Review, H1 2020 US$ 2,000.00

... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 151 pages
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 31 pages
Phenylketonuria (PKU) - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Phenylketonuria (PKU) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 82 pages
Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H1 2020 US$ 2,000.00

Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome - Pipeli...

January 2020 62 pages
Cerebral Palsy - Pipeline Review, H1 2020 US$ 2,000.00

... . The Cerebral Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cerebral Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 47 pages
Autism - Pipeline Review, H1 2020 US$ 2,000.00

... . The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 177 pages
Down Syndrome - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Down Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Down Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 80 pages
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 35 pages
Otitis Media - Pipeline Review, H1 2020 US$ 2,000.00

... . The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 78 pages
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2020 US$ 2,000.00

... . The Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 107 pages
Urinary Incontinence - Pipeline Review, H1 2020 US$ 2,000.00

... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2020 74 pages
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Venous Leg Ulcers (Crural ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 68 pages
Alopecia - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 190 pages
Colitis - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 121 pages
Diarrhea - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 153 pages
Fatigue - Pipeline Review, H1 2020 US$ 2,000.00

... . The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 39 pages
Tourette Syndrome - Pipeline Review, H1 2020 US$ 2,000.00

... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 86 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020 US$ 2,000.00

... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2020 197 pages
Alcohol Addiction - Pipeline Review, H1 2020 US$ 2,000.00

... . The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 183 pages
Ischemia Reperfusion Injury - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 177 pages
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2020 US$ 2,000.00

... releases. The Systemic Sclerosis (Scleroderma) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Sclerosis (Scleroderma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2020 374 pages

Filters

Search

Categories

838
438
595
2
54
6
2
12
1
1
2
4
6
1
6
14
1

Publishers

1,983

Regions

1,983

Price

Date

Pages

Offers